News Releases – News & Events | Oncolytics Biotech Inc.

News Releases

Latest News Release

Dec 22, 2014

Oncolytics Biotech^® Inc. Announces Filing for Orphan Designation with the EMA for Pancreatic and Ovarian Cancers

Dec 4, 2014

Oncolytics Biotech^® Inc. Collaborators Present REOLYSIN^® and Checkpoint Inhibitor Combination Preclinical Data at AACR Tumor Immunology and Immunotherapy Conference

Dec 2, 2014

Oncolytics Biotech^® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Pancreatic and Ovarian Cancers

Nov 18, 2014

Media Advisory – Oncolytics Biotech^® Inc. to Participate in the Stifel 2014 Healthcare Conference

Nov 6, 2014

Oncolytics Biotech^® Inc. Announces Third Quarter 2014 Results

Nov 4, 2014

Oncolytics Biotech^® Inc. Announces Receipt of Nasdaq Notice of Deficiency

Oct 24, 2014

Oncolytics Biotech^® Inc. Announces Entry Into $20 Million "At-The-Market" Equity Distribution Agreement with Canaccord Genuity Inc.

Oct 20, 2014

Oncolytics Biotech^® Inc. Announces Amendment to Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC

1
2
3
4